These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Prognostic value of right ventricular systolic function in cardiac amyloidosis. Bodez D; Ternacle J; Guellich A; Galat A; Lim P; Radu C; Guendouz S; Bergoend E; Couetil JP; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Deux JF; Mohty D; Damy T Amyloid; 2016 Sep; 23(3):158-167. PubMed ID: 27348696 [TBL] [Abstract][Full Text] [Related]
27. Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy. Hoigné P; Attenhofer Jost CH; Duru F; Oechslin EN; Seifert B; Widmer U; Frischknecht B; Jenni R Int J Cardiol; 2006 Aug; 111(3):413-22. PubMed ID: 16307805 [TBL] [Abstract][Full Text] [Related]
28. Focus on cardiac amyloidosis: a single-center experience with a long-term follow-up. Finocchiaro G; Pinamonti B; Merlo M; Giannini F; Barbati G; Pivetta A; Santarossa E; Doimo S; DePellegrin A; Bussani R; Sinagra G J Cardiovasc Med (Hagerstown); 2013 Apr; 14(4):281-8. PubMed ID: 22609869 [TBL] [Abstract][Full Text] [Related]
29. [The isolated form of cardiac amyloidosis in the form of beginning infiltrative cardiomyopathy without restrictive physiology]. Kuchynka P; Palecek T; Simek S; Lubanda JC; Elleder M; Spicka I; Jansa P; Linhart A Vnitr Lek; 2008 Oct; 54(10):1010-3. PubMed ID: 19009770 [TBL] [Abstract][Full Text] [Related]
30. Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac Amyloidosis. Ternacle J; Bodez D; Guellich A; Audureau E; Rappeneau S; Lim P; Radu C; Guendouz S; Couetil JP; Benhaiem N; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Mohty D; Deux JF; Damy T JACC Cardiovasc Imaging; 2016 Feb; 9(2):126-38. PubMed ID: 26777222 [TBL] [Abstract][Full Text] [Related]
31. Left ventricular device implantation for advanced cardiac amyloidosis. Swiecicki PL; Edwards BS; Kushwaha SS; Dispenzieri A; Park SJ; Gertz MA J Heart Lung Transplant; 2013 May; 32(5):563-8. PubMed ID: 23474361 [TBL] [Abstract][Full Text] [Related]
32. Transplant candidates with severe left ventricular dysfunction managed with medical treatment: characteristics and survival. Rickenbacher PR; Trindade PT; Haywood GA; Vagelos RH; Schroeder JS; Willson K; Prikazsky L; Fowler MB J Am Coll Cardiol; 1996 Apr; 27(5):1192-7. PubMed ID: 8609341 [TBL] [Abstract][Full Text] [Related]
33. Left atrial size is an independent predictor of overall survival in patients with primary systemic amyloidosis. Mohty D; Pibarot P; Dumesnil JG; Darodes N; Lavergne D; Echahidi N; Virot P; Bordessoule D; Jaccard A Arch Cardiovasc Dis; 2011 Dec; 104(12):611-8. PubMed ID: 22152513 [TBL] [Abstract][Full Text] [Related]
34. Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis. Ng B; Connors LH; Davidoff R; Skinner M; Falk RH Arch Intern Med; 2005 Jun; 165(12):1425-9. PubMed ID: 15983293 [TBL] [Abstract][Full Text] [Related]
35. Prognostic value of fragmented QRS in cardiac AL amyloidosis. Perlini S; Salinaro F; Cappelli F; Perfetto F; Bergesio F; Alogna A; Mussinelli R; Boldrini M; Raimondi A; Musca F; Palladini G; Merlini G Int J Cardiol; 2013 Sep; 167(5):2156-61. PubMed ID: 22748496 [TBL] [Abstract][Full Text] [Related]
36. Detection of left ventricular systolic dysfunction in cardiac amyloidosis with strain rate echocardiography. Bellavia D; Abraham TP; Pellikka PA; Al-Zahrani GB; Dispenzieri A; Oh JK; Bailey KR; Wood CM; Novo S; Miyazaki C; Miller FA J Am Soc Echocardiogr; 2007 Oct; 20(10):1194-202. PubMed ID: 17596912 [TBL] [Abstract][Full Text] [Related]
37. Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. Austin BA; Tang WH; Rodriguez ER; Tan C; Flamm SD; Taylor DO; Starling RC; Desai MY JACC Cardiovasc Imaging; 2009 Dec; 2(12):1369-77. PubMed ID: 20083070 [TBL] [Abstract][Full Text] [Related]
38. Frequencies and types of arrhythmias in patients with systemic light-chain amyloidosis with cardiac involvement undergoing stem cell transplantation on telemetry monitoring. Goldsmith YB; Liu J; Chou J; Hoffman J; Comenzo RL; Steingart RM Am J Cardiol; 2009 Oct; 104(7):990-4. PubMed ID: 19766769 [TBL] [Abstract][Full Text] [Related]
39. [Cardiac amyloidosis: a case series of 14 patients, description and prognosis]. Isabel C; Georgin-Lavialle S; Aouba A; Delarue R; Nochy D; Karras A; Azarine A; Hermine O; Ranque B; Hagège A; Pouchot J Rev Med Interne; 2013 Nov; 34(11):671-8. PubMed ID: 24090573 [TBL] [Abstract][Full Text] [Related]
40. Heart transplantation in patients with amyloidosis: single-center experience. Alloni A; Pellegrini C; Ragni T; Goggi C; D'Armini AM; Rinaldi M; Viganò M Transplant Proc; 2004 Apr; 36(3):643-4. PubMed ID: 15110619 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]